MCO
80
2
DNB
50
-4
RSG
59
2
TROW
34
-5
FOXA
48
7
XRAY
31
-3
HOG
50
6
BIIB
37
7
STT
51
-5
MOS
19
-4
ADM
33
-3
NTAP
60
2
AMG
41
-3
BRK.B
42
-3
PYPL
43
-4
FTI
82
4
FRT
36
-2
O
31
3
CMG
51
-3
WU
12
-4
MCO
80
2
DNB
50
-4
RSG
59
2
TROW
34
-5
FOXA
48
7
XRAY
31
-3
HOG
50
6
BIIB
37
7
STT
51
-5
MOS
19
-4
ADM
33
-3
NTAP
60
2
AMG
41
-3
BRK.B
42
-3
PYPL
43
-4
FTI
82
4
FRT
36
-2
O
31
3
CMG
51
-3
WU
12
-4
Financhill
Back

Okta Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
45

OKTA
Okta

Last Price:
75.78
Seasonality Move:
2.62%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
45
Okta (OKTA) is a Sell

Is Okta a Buy, Sell or Hold?

  • The current Okta [OKTA] share price is $75.79. The Score for OKTA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • OKTA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OKTA Stock Price Chart

What is Okta's stock price today?

  • The Okta share price today is $75.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OKTA is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

OKTA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.43 Sell
Relative Strength Index (14 RSI): 36.64 Sell
Chaikin Money Flow: 2506202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.65 - 93.99) Sell
Bollinger Bands (100): (82.45 - 98.93) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

OKTA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.24 Buy
20-day SMA: 79.16 Sell
50-day SMA: 87.72 Sell
200-day SMA: 91.09 Sell
8-day EMA: 74.87 Buy
20-day EMA: 78.53 Sell
50-day EMA: 84.74 Sell
200-day EMA: 88.53 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Okta Earnings Growth & OKTA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.14 per share, an increase this year of $1.76 per share, and an increase next year of $1.13 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Okta Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):